Lawrence M. Blatt

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ALGS

Current role

CEO, Board Member

2018-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Aligos Therapeutics, Inc. (ALGS)	Ph.D., M.B.A. President and Chief Executive Officer	$651,718	—	—	$3,014,995	$371,479	$19,042	$4,057,234
2024	Aligos Therapeutics, Inc. (ALGS)	Ph.D., M.B.A. President and Chief Executive Officer	$626,652	—	—	$1,129,049	$361,892	$17,690	$2,135,283
2023	Aligos Therapeutics, Inc. (ALGS)	Ph.D., M.B.A. President and Chief Executive Officer	$587,495	—	—	$311,690	$393,179	$52,094	$1,344,458
2022	Aligos Therapeutics, Inc. (ALGS)	President and Chief Executive Officer	$548,653	—	—	$1,018,403	$241,408	$42,664	$1,851,128
2021	Aligos Therapeutics, Inc. (ALGS)	Ph.D., Chief Executive Officer	$548,653	—	—	—	$282,749	$41,179	$872,582
2020	Aligos Therapeutics, Inc. (ALGS)	Ph.D., Chief Executive Officer	$492,654	—	—	$6,500,620	$364,444	$42,984	$7,400,702
2019	Aligos Therapeutics, Inc. (ALGS)	Ph.D., Chief Executive Officer	$475,000	—	—	—	$180,500	$18,866	$674,366

No earnings-call appearances or filed executive changes recorded yet.